TIAA FSB’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-2,935
| Closed | -$215K | – | 587 |
|
2022
Q4 | $215K | Hold |
2,935
| – | – | ﹤0.01% | 530 |
|
2022
Q3 | $223K | Sell |
2,935
-11
| -0.4% | -$836 | ﹤0.01% | 520 |
|
2022
Q2 | $205K | Buy |
+2,946
| New | +$205K | ﹤0.01% | 566 |
|
2021
Q3 | – | Sell |
-13,741
| Closed | -$3.05M | – | 389 |
|
2021
Q2 | $3.05M | Hold |
13,741
| – | – | 0.01% | 224 |
|
2021
Q1 | $1.82M | Hold |
13,741
| – | – | 0.01% | 259 |
|
2020
Q4 | $2.38M | Buy |
+13,741
| New | +$2.38M | 0.01% | 226 |
|
2019
Q2 | – | Sell |
-13,741
| Closed | -$662K | – | 309 |
|
2019
Q1 | $662K | Hold |
13,741
| – | – | 0.01% | 284 |
|
2018
Q4 | $460K | Hold |
13,741
| – | – | ﹤0.01% | 309 |
|
2018
Q3 | $720K | Hold |
13,741
| – | – | ﹤0.01% | 294 |
|
2018
Q2 | $430K | Hold |
13,741
| – | – | ﹤0.01% | 327 |
|
2018
Q1 | $300K | Hold |
13,741
| – | – | ﹤0.01% | 353 |
|
2017
Q4 | $278K | Hold |
13,741
| – | – | ﹤0.01% | 375 |
|
2017
Q3 | $273K | Hold |
13,741
| – | – | ﹤0.01% | 369 |
|
2017
Q2 | $238K | Buy |
+13,741
| New | +$238K | ﹤0.01% | 361 |
|